Skip to main content
Premium Trial:

Request an Annual Quote

VWR to Distribute SynX Diagnostics in Canada

NEW YORK, March 27 - VWR International has a signed a three-year contract with SynX to distribute its point-of-care diagnostic products in Canada, the SynX said today.


The agreement will begin April 1, and by mid-month VWR will begin selling SynX's myocardial-infarction test. "In the near term" the partnership also intends to launch point-of-care tests for traumatic brain injury and congestive heart failure.


Both firms are based on Toronto.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.